WSGR logoWSGR logo
WSGR logo
  • Experience
  • People
  • Insights
  • About Us
  • Careers

  • Practice Areas
  • Industries

  • Corporate
  • Intellectual Property
  • Litigation
  • Patents and Innovations
  • Regulatory
  • Technology Transactions

  • Capital Markets
  • Corporate Governance
  • Corporate Life Sciences
  • Derivatives
  • Emerging Companies and Venture Capital
  • Employee Benefits and Compensation
  • Energy and Climate Solutions
  • Executive Advisory Program
  • Finance and Structured Finance
  • Fund Formation
  • Greater China
  • Mergers & Acquisitions
  • Private Equity
  • Public Company Representation
  • Real Estate
  • Restructuring
  • Shareholder Engagement and Activism
  • Tax
  • U.S. Expansion
  • Wealthtech

  • Special Purpose Acquisition Companies (SPACs)

  • Environmental, Social, and Governance

  • AI and Data Center Infrastructure
  • Energy Regulation and Competition
  • Project Development and M&A
  • Project Finance and Tax Credit Transactions
  • Sustainability and Decarbonization
  • Transportation Electrification

  • U.S. Expansion Library and Resources

  • Post-Grant Review
  • Trademark and Advertising

  • Antitrust Litigation
  • Arbitration
  • Board and Internal Investigations
  • Class Action Litigation
  • Commercial Litigation
  • Consumer Litigation
  • Corporate Governance Litigation
  • Employment Litigation
  • Executive Branch Updates
  • Government Investigations
  • Internet Strategy and Litigation
  • Patent Litigation
  • Securities Litigation
  • State Attorneys General
  • Supreme Court and Appellate Practice
  • Trade Secret Litigation
  • Trademark and Copyright Litigation
  • Trial
  • White Collar Crime

  • Advertising, Promotions, and Marketing
  • Antitrust and Competition
  • Committee on Foreign Investment in the U.S. (CFIUS)
  • Communications
  • Data, Privacy, and Cybersecurity
  • Export Control and Sanctions
  • FCPA and Anti-Corruption
  • FDA Regulatory, Healthcare, and Consumer Products
  • Federal Trade Commission
  • Fintech and Financial Services
  • Government Contracts
  • National Security and Trade
  • Payments
  • State Attorneys General
  • Strategic Risk and Crisis Management
  • Tariffs, Customs, and Import Compliance

  • Antitrust and Intellectual Property
  • Antitrust Civil Enforcement
  • Antitrust Compliance and Business Strategy
  • Antitrust Criminal Enforcement
  • Antitrust Litigation
  • Antitrust Merger Clearance
  • European Competition Law
  • Third-Party Merger and Non-Merger Antitrust Representation

  • Anti-Money Laundering
  • Foreign Ownership, Control, or Influence (FOCI)
  • Team Telecom

  • AI in Healthcare
  • Animal Health
  • Artificial Intelligence and Machine Learning
  • Aviation
  • Biotech
  • Blockchain and Cryptocurrency
  • Clean Energy
  • Climate and Clean Technologies
  • Communications and Networking
  • Consumer Products and Services
  • Data Storage and Cloud
  • Defense Tech
  • Diagnostics, Life Science Tools, and Deep Tech
  • Digital Health
  • Digital Media and Entertainment
  • Electronic Gaming
  • Fintech and Financial Services
  • FoodTech and AgTech
  • Global Generics
  • Internet
  • Life Sciences
  • Medical Devices
  • Mobile Devices
  • Mobility
  • NewSpace
  • Quantum Computing
  • Semiconductors
  • Software

  • Offices
  • Country Desks
  • Events
  • Community
  • Our Diversity
  • Sustainability
  • Our Values
  • Board of Directors
  • Management Team

  • Austin
  • Boston
  • Boulder
  • Brussels
  • Century City
  • Hong Kong
  • London
  • Los Angeles
  • New York
  • Palo Alto
  • Salt Lake City
  • San Diego
  • San Francisco
  • Seattle
  • Shanghai
  • Washington, D.C.
  • Wilmington, DE

  • Law Students
  • Judicial Clerks
  • Experienced Attorneys
  • Patent Agents
  • Business Professionals
  • Alternative Legal Careers
  • Contact Recruiting
Dalton Case
Associate
Patents and Innovations
San Diego
dcase@wsgr.com

D858-350-2386

Download vCard
Open PDF

Dalton Case is an associate in the San Diego office of Wilson Sonsini Goodrich & Rosati. His practice focuses on patent prosecution, serving clients in the chemical, biotechnology, and software industries.

Dalton served as an extern for Judge Bernard Skomal during law school, where he was introduced to patent litigation and discovery. He was also a patent intern at Patterson + Sheridan, LLP during law school, where he assisted with serving clients in the chemical engineering and software industry.

Dalton gained extensive experience in chemical engineering through his undergraduate research at UCLA, where he assisted in designing an ammonia plant in China. Before law school, he also worked at a San Diego winery, where he tested wine in the lab and helped determine flow processes.

Experience

Dalton Case is an associate in the San Diego office of Wilson Sonsini Goodrich & Rosati. His practice focuses on patent prosecution, serving clients in the chemical, biotechnology, and software industries.

Dalton served as an extern for Judge Bernard Skomal during law school, where he was introduced to patent litigation and discovery. He was also a patent intern at Patterson + Sheridan, LLP during law school, where he assisted with serving clients in the chemical engineering and software industry.

Dalton gained extensive experience in chemical engineering through his undergraduate research at UCLA, where he assisted in designing an ammonia plant in China. Before law school, he also worked at a San Diego winery, where he tested wine in the lab and helped determine flow processes.

Education
  • J.D., University of San Diego School of Law, 2020
  • B.S. Chemical Engineering, University of California, Los Angeles, 2016
Admissions
  • State Bar of California
  • U.S. Patent and Trademark Office
Credentials
Education
  • J.D., University of San Diego School of Law, 2020
  • B.S. Chemical Engineering, University of California, Los Angeles, 2016
Admissions
  • State Bar of California
  • U.S. Patent and Trademark Office

Biological Sciences and Biotechnology

  • Biochemical assays
  • Molecular biology
  • Stem cell biology

Therapeutics and Drug Discovery

  • Gene therapy

Diagnostics and Medical Devices

  • Biomedical devices
  • Medical devices
  • Medical imaging

Chemistry and Material Science

  • Materials chemistry

Engineering and Technology

  • AI
  • Computer science
  • Machine learning
  • Microfluidics

Miscellaneous

  • Design patent
Technical Fluency

Biological Sciences and Biotechnology

  • Biochemical assays
  • Molecular biology
  • Stem cell biology

Therapeutics and Drug Discovery

  • Gene therapy

Diagnostics and Medical Devices

  • Biomedical devices
  • Medical devices
  • Medical imaging

Chemistry and Material Science

  • Materials chemistry

Engineering and Technology

  • AI
  • Computer science
  • Machine learning
  • Microfluidics

Miscellaneous

  • Design patent
Focus Areas
  • Biotech
  • Patents and Innovations
  • Software
Recent Insights
Client Highlights
Wilson Sonsini Advises Think Bioscience on Patent Matters Related to Oversubscribed $55 Million Series A
On January 20, 2026, Think Bioscience (Think Bio), a Boulder-based biotechnology company focused on unlocking elusive drug targets, has raised $55 million in an oversubscribed Series A. The round was led by Regeneron Ventures, Innovation Endeavors, and Janus Henderson Investors with participation from T.A. Springer, CE-Ventures, MBX Capital, and YK Bioventures. Returning investors include AV8 Ventures, CU Innovations, and Buff Gold Ventures. Wilson Sonsini Goodrich & Rosati advised Think Bio on patent matters related to the transaction.
Learn More
Client Highlights
Wilson Sonsini Advises Iambic Therapeutics on $50 Million Series B Extension, Bringing Total Series B Funding to Over $150 Million
On June 18, 2024, Iambic Therapeutics (Iambic), a clinical-stage biotechnology company developing novel therapeutics from its unique generative AI discovery platform, announced the closing of an oversubscribed $50 million extension, bringing the total Series B funding to over $150 million. The Series B extension was led by new investors Mubadala Capital and Exor Ventures, and existing investors Abingworth, Illumina Ventures, Nexus Venture Partners, Coatue, and Tao Capital Partners. Wilson Sonsini Goodrich & Rosati advised Iambic on the transaction.
Learn More
View All
  • people
  • insights
  • about us
  • careers
  • Binder
  • Alumni
  • Mailing List Signup
  • Client FTP Portal
  • Privacy Policy
  • Terms of Use
  • Accessibility
WSGR logo
Twitter
LinkedIn
Facebook
Instagram
Youtube
Copyright © 2026 Wilson Sonsini Goodrich & Rosati. All Rights Reserved.